REGN Next Earnings Date Notes

— Regeneron Pharmaceuticals (REGN) is a leading biotechnology company focused on discovering, developing, and commercializing medicines for serious diseases in areas such as ophthalmology, immunology, oncology, and rare diseases. Their key products include EYLEA® (aflibercept) for retinal diseases, Dupixent® for allergic & inflammatory conditions, and Libtayo® in cancer. When monitoring Regeneron’s long-term prospects, pay close attention to metrics such as EYLEA & Dupixent sales growth (including share of U.S. vs. ex-U.S. revenues), R&D pipeline updates (notably trial progress & key regulatory milestones), and operating margins. Additionally, watch for management commentary regarding market expansion, potential biosimilar competition, partnerships (notably with Sanofi), and cash flow trends as indicators of sustainable growth & innovation. Pipeline advancements—like antibody platform updates or new approvals—can be major catalysts. On the earnings call, listening for color around ongoing clinical trials, guidance updates, and strategy for long-term market leadership can provide important context for interpreting headline financials. The next projected earnings date for REGN is 7/31/2026 6:00 am (stay tuned for a confirmed earnings date once announced).

REGN Next Earnings Date FAQ

On this page we presented the REGN Next Earnings Date information for Regeneron Pharmaceuticals along with recent past earnings dates. For Q1 of 2026, REGN reported earnings of 9.470/share, with the earnings report taking place on 4/29/2026. For Q4 of 2025, REGN reported earnings of 11.440/share, with the earnings report taking place on 1/30/2026. For Q3 of 2025, REGN reported earnings of 11.830/share, with the earnings report taking place on 10/28/2025. For Q2 of 2025, REGN reported earnings of 12.890/share, with the earnings report taking place on 8/1/2025. For Q1 of 2025, REGN reported earnings of 8.220/share, with the earnings report taking place on 4/29/2025. Based on these past earnings dates, the projected next earnings date for REGN is 7/31/2026 6:00 am.

Any self directed investor who desires to keep tabs on the companies they own, can benefit from maintaining a calendar of next earnings dates for each stock in their porfolio, such as Regeneron Pharmaceuticals. When a company files its 10Q's with the SEC a mere four times a year, that certainly puts a lot of pressure on those four out of three hundred sixty five days! To say that earnings reports are important to Regeneron Pharmaceuticals shareholders would thus be an understatement! That's why we started the NextEarningsDate.com website, to make it easy for self directed investors to research Regeneron Pharmaceuticals next earnings dates as well as any other stock out there in our coverage universe, to see when the next REGN earnings date — or any other stock — falls on the calendar. But we also present considerably more than just the next earnings date information alone, so we encourage you to explore the additional pages linked above to look up REGN's past earnings as well, with pages for revenue and earnings history data, as well as earnings surprises as well. Thanks for visiting, and we hope you'll think of our site the next time you need to learn about the REGN next earnings date.